ArticleBladder cancer (Amsterdam, Netherlands)2017

Oncological Outcomes of Sequential Intravesical Gemcitabine and Docetaxel in Patients with Non-Muscle Invasive Bladder Cancer.

Niv Milbar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.